Abel Hall LLC
NVAX icon

Abel Hall LLC’s Novavax NVAX Stock Holding History

Abel Hall LLC’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$170K Sell
15,701
-1,892
-11% -$17K 0.03% 725
2026
Q2 		$166K Sell
17,593
-457
-3% -$4.1K 0.03% 773
2026
Q1 		$147K Buy
18,050
+4,241
+31% +$38.4K 0.03% 655
2025
Q4 		$92.8K Buy
+13,809
New +$104K 0.02% 615

Other funds holding NVAX

Shah Capital Management
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
TSP Capital Management Group
TSP Capital Management Group Summit, New Jersey $397M AUM 31.23% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Independent Financial Group
Independent Financial Group San Diego, California $5.51B AUM 33.51% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Abel Hall LLC's NVAX Position: Q3 2026 in Review

Abel Hall LLC reduced its Novavax (NVAX) stake by 11% in Q3 2026, selling an estimated $17K and leaving 15,701 shares worth $170K. The position accounts for 0.03% of the portfolio, ranked #725.

Abel Hall LLC first reported a position in NVAX in Q4 2025 and has held it in 4 quarters since. 56 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • Abel Hall LLC held 15,701 shares of Novavax worth $170K as of Q3 2026.
  • Abel Hall LLC sold 1,892 Novavax shares in Q3 2026, an estimated $17K.
  • Novavax made up 0.03% of Abel Hall LLC's portfolio in Q3 2026, its #725 holding.
  • Abel Hall LLC first reported a position in Novavax in Q4 2025 and has held it in 4 quarters since.
  • 56 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.